Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

839 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.
Kickingereder P, Neuberger U, Bonekamp D, Piechotta PL, Götz M, Wick A, Sill M, Kratz A, Shinohara RT, Jones DTW, Radbruch A, Muschelli J, Unterberg A, Debus J, Schlemmer HP, Herold-Mende C, Pfister S, von Deimling A, Wick W, Capper D, Maier-Hein KH, Bendszus M. Kickingereder P, et al. Among authors: von deimling a. Neuro Oncol. 2018 May 18;20(6):848-857. doi: 10.1093/neuonc/nox188. Neuro Oncol. 2018. PMID: 29036412 Free PMC article.
TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.
Kraus JA, Wenghoefer M, Glesmann N, Mohr S, Beck M, Schmidt MC, Schröder R, Berweiler U, Roggendorf W, Diete S, Dietzmann K, Heuser K, Müller B, Fimmers R, von Deimling A, Schlegel U. Kraus JA, et al. Among authors: von deimling a. J Neurooncol. 2001 May;52(3):263-72. doi: 10.1023/a:1010684203704. J Neurooncol. 2001. PMID: 11519857
No preferential loss of paternal 19q alleles in oligodendroglial tumors.
Hartmann C, Mueller W, Lass U, Stockhammer F, von Eckardstein K, Veelken J, Jeuken J, Wick W, von Deimling A. Hartmann C, et al. Among authors: von deimling a, von eckardstein k. Ann Neurol. 2003 Aug;54(2):256-8. doi: 10.1002/ana.10649. Ann Neurol. 2003. PMID: 12891681
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma.
Jordan A, Scholz R, Maier-Hauff K, van Landeghem FK, Waldoefner N, Teichgraeber U, Pinkernelle J, Bruhn H, Neumann F, Thiesen B, von Deimling A, Felix R. Jordan A, et al. Among authors: von deimling a. J Neurooncol. 2006 May;78(1):7-14. doi: 10.1007/s11060-005-9059-z. Epub 2005 Nov 29. J Neurooncol. 2006. PMID: 16314937
Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme.
Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, von Deimling A, Waldoefner N, Felix R, Jordan A. Maier-Hauff K, et al. Among authors: von deimling a. J Neurooncol. 2007 Jan;81(1):53-60. doi: 10.1007/s11060-006-9195-0. Epub 2006 Jun 14. J Neurooncol. 2007. PMID: 16773216 Clinical Trial.
839 results